Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum Triglycerides and Atherosclerotic Cardiovascular Disease: Insights from Clinical and Genetic Studies

17 Nov 2018

Abstract excerpt

Lipoproteins are a major risk factor for atherosclerotic cardiovascular diseases (ASCVD). Among the lipoproteins, low-density lipoproteins (LDL) have been shown to be causally associated with ASCVD development. In contrast, triglycerides or triglyceride-rich lipoproteins receive less attention than LDL because there is little definite evidence from randomized controlled trials. A Mendelian randomization study has...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes, Cardiovascular Risks, and Lipoproteins
Share to Genetic Associations and Epidemiology
Share to Lipoproteins and Cardiovascular Health

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30453617
DOI: 10.3390/nu10111789

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum Triglycerides and Atherosclerotic Cardiovascular Disease: Insights from Clinical and Genetic StudiesPMID 30453617Read ↗

Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology.Semantic proximity Read ↗

Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease.Semantic proximity Read ↗

Genetics of Triglycerides and the Risk of AtherosclerosisSemantic proximity Read ↗

Genetics of Triglyceride-Rich Lipoproteins Guide Identification of Pharmacotherapy for Cardiovascular Risk Reduction.Semantic proximity Read ↗

Genetics of hypertriglyceridemia and atherosclerosisSemantic proximity Read ↗

Genetic determinants of lipids and cardiovascular disease outcomes: a wide-angled Mendelian randomization investigationSemantic proximity Read ↗

Genetic Determinants of Lipids and Cardiovascular Disease Outcomes: A Wide-Angled Mendelian Randomization Investigation.Semantic proximity Read ↗

Triglycerides and ASCVD Risk Reduction: Recent Insights and Future Directions.Semantic proximity Read ↗

Triglyceride-rich lipoproteins and coronary artery disease risk: new insights from human genetics.Semantic proximity Read ↗

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.Semantic proximity Read ↗

Common variants associated with plasma triglycerides and risk for coronary artery disease.Semantic proximity Read ↗

Mendelian randomization of blood lipids for coronary heart disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.